InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Kolaja Carey OConnor. Director active across 1 company, notably Revance Therapeutics, Inc.. Aggregated, 7 disclosures have been logged. Activity tracked since 5 May 2021. The latest transaction was filed on 4 February 2025 (U). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
16,561 shares@ US$3.6558.6% of flowCommon StockSEC:0000950170-25-015353:0
15,000 shares0Common StockSEC:0001479290-24-000087:0
2,500 shares@ US$18.1241.4% of flowCommon StockSEC:0001479290-23-000080:0
3,534 shares0Common StockSEC:0001479290-23-000061:0
6,059 shares0Common StockSEC:0001479290-22-000062:0
674 shares0Common StockSEC:0001479290-21-000110
674 shares0Common StockSEC:0001479290-21-000110:0
7 of 7 declarations
